ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Emerald Health Starts Activities for Initiation of Phase 2 Clinical Study in Multiple Sclerosis
March 11, 2021Emerald Health Pharmaceuticals (EHP) has initiated activities for a Phase 2 international clinical study for the treatment of patients with multiple sclerosis (MS). -
Emerald Health Begins Enrollment for Systemic Sclerosis Treatment Study
August 03, 2020Emerald Health Pharmaceuticals (EHP) has begun enrollment and has dosed its first patients with diffuse cutaneous systemic sclerosis (dcSSc) in its Phase 2a clinical study of its lead product candidate, EHP-101.
Pharma Sources Insight January 2025
